- Home
- BLNK vs SGHT Comparison
BLNK vs SGHT Comparison
Compare BLNK & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- SGHT
- Stock Information
- Founded
- BLNK 2009
- SGHT 2011
- Country
- BLNK United States
- SGHT United States
- Employees
- BLNK N/A
- SGHT N/A
- Industry
- BLNK Industrial Specialties
- SGHT Medical Specialities
- Sector
- BLNK Consumer Discretionary
- SGHT Health Care
- Exchange
- BLNK Nasdaq
- SGHT Nasdaq
- Market Cap
- BLNK 163.4M
- SGHT 304.4M
- IPO Year
- BLNK N/A
- SGHT 2021
- Fundamental
- Price
- BLNK $1.52
- SGHT $3.55
- Analyst Decision
- BLNK Buy
- SGHT Buy
- Analyst Count
- BLNK 7
- SGHT 7
- Target Price
- BLNK $5.64
- SGHT $6.27
- AVG Volume (30 Days)
- BLNK 4.6M
- SGHT 218.9K
- Earning Date
- BLNK 11-07-2024
- SGHT 11-07-2024
- Dividend Yield
- BLNK N/A
- SGHT N/A
- EPS Growth
- BLNK N/A
- SGHT N/A
- EPS
- BLNK N/A
- SGHT N/A
- Revenue
- BLNK $138,728,000.00
- SGHT $79,543,000.00
- Revenue This Year
- BLNK N/A
- SGHT $2.13
- Revenue Next Year
- BLNK $22.16
- SGHT $7.99
- P/E Ratio
- BLNK N/A
- SGHT N/A
- Revenue Growth
- BLNK 15.13
- SGHT N/A
- 52 Week Low
- BLNK $1.42
- SGHT $3.30
- 52 Week High
- BLNK $4.48
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- BLNK 43.10
- SGHT 39.11
- Support Level
- BLNK $1.42
- SGHT $3.30
- Resistance Level
- BLNK $1.54
- SGHT $3.64
- Average True Range (ATR)
- BLNK 0.11
- SGHT 0.20
- MACD
- BLNK -0.00
- SGHT 0.02
- Stochastic Oscillator
- BLNK 23.26
- SGHT 30.67
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.